Navigation Links
Profil Institute Reports Record Growth in Number of Clinical Trials in the Pipeline
Date:5/3/2012

SAN DIEGO, May 3, 2012 /PRNewswire/ -- Profil® Institute for Clinical Research, Inc., a company focused on early phase clinical trials for diabetes and obesity, announced today record growth in the number of clinical trials in the pipeline.  Profil Institute also reports an increase in the number of mid-size biotech and off-shore clients, while maintaining active collaborations with the largest global pharmaceutical companies, driven by a strong demand for Phase I and metabolic disease specialization. 

Profil Institute's advances in early phase drug research and its specific focus on diabetes, obesity and cardiometabolic diseases as it relates to the diabetic patient population have led Profil Institute to be recognized in the pharmaceutical community as the most highly regarded clinical research institute for early phase diabetes drug trials. 

"Pharmaceutical clients are facing increased pressure to be more selective and efficient with their drug candidate trials and as such are turning to specialized institutes like Profil Institute to run more complex and meaningful studies," said Profil Institute CEO Dr. Marcus Hompesch.  "While other CROs are responding to this trend, specialization has been Profil Institute's strategy since the company's inception and our business has grown as a result.  We now have a record number of projects in our pipeline, active collaborations with the largest global pharmaceutical companies, and a rapidly growing number of mid-size pharmaceutical and biotech clients."

Although considered a CRO (Clinical Research Organization), the founders of Profil Institute have never considered their company to accurately fit that description.  Instead they coined the term CRI, Clinical Research Institute, and define it as"uniting independent academic science with the professionalism of the pharmaceutical industry" – combining distinct academic intellect with the means to effec
'/>"/>

SOURCE Profil Institute for Clinical Research, Inc.
Copyright©2010 PR Newswire.
All rights reserved

Page: 1 2 3

Related biology technology :

1. Profil Institute Continues to Publish New Findings in Metabolic Research
2. Profiler at the cellular level
3. Genesis Biopharma Director William H. Andrews, Ph.D., Profiled in Popular Science Feature Story
4. Halozymes Ultrafast Insulin Generates Faster-In and Faster-Out Profile for Type 1 Diabetes Patients Using Insulin Pumps
5. Precision Therapeutics Announces New Tumor Profiling Product to Augment Utility of ChemoFx® and Further Personalize Cancer Treatment
6. Cempra Pharmaceuticals Profiles the Broad Spectrum and Potent Activity Profile of Solithromycin (CEM-101) at the 5th Annual PHEMCE Stakeholders Workshop and BARDA Industry Day
7. Reportlinker Adds Merck KGaA: PharmaVitae Profile
8. Reportlinker Adds Cancer Profiling and Pathways: Technologies and Global Markets
9. Reportlinker Adds Shire plc: PharmaVitae Profile
10. Promega Now Offers Complete Solution for Profiling Kinase Inhibitor Compounds Against the Human Kinome
11. DURATION-4 Study Results: BYDUREON Efficacy and Tolerability Profile Extended to Monotherapy Treatment
Post Your Comments:
*Name:
*Comment:
*Email:
(Date:11/21/2014)... Palo Alto, Calif. (PRWEB) November 20, 2014 ... (CHI), a nonprofit, public policy research organization representing ... and pharmaceutical firms, and PwC US ... other states in life sciences industry growth. The ... and 2013. The 2015 California Biomedical Industry ...
(Date:11/21/2014)... (PRWEB) November 21, 2014 2014 ... Ferrocyanide Industry” is a professional and in-depth research ... Sodium ferrocyanide information, like its definition, classification, ... industry overview. This report covers the international market ... global (such as the US, Europe, Asia, China, ...
(Date:11/21/2014)... ON , Nov. 20, 2014 /PRNewswire/ - BIOREM Inc. (TSXV: BRM) ... and nine month periods ended September 30, 2014.  Biorem,s complete 2014 ... ( www.sedar.com ). Financial Summary:Three-months ended September ... except per share data) , 2014 , ... 2,282 , 5,281 , 6,715 ...
(Date:11/18/2014)... Athena Signature Series: Turning Cancer ‘Off’ – featuring Dr. ... in the Regulatory Biology Laboratory at the Salk Institute, studies ... an “off switch” for drug resistance in cancer. , Learn ... is making a global impact in the fight against cancer. ... Cheryl K. Goodman, CEO of Social Global Mobile LLC, for ...
Breaking Biology Technology:California Healthcare Institute and PwC Report Boom in California’s Biomedical Industry 2California Healthcare Institute and PwC Report Boom in California’s Biomedical Industry 3California Healthcare Institute and PwC Report Boom in California’s Biomedical Industry 4Sodium Ferrocyanide Market: Analysis for Global & China Regions Development Trends Available at DeepResearchReports.com 2Sodium Ferrocyanide Market: Analysis for Global & China Regions Development Trends Available at DeepResearchReports.com 3Biorem Reports Third Quarter Results 2Biorem Reports Third Quarter Results 3
... YORK, Aug. 10 ExL Pharma is pleased ... many of the leading issues that are,impacting the ... offer educational and networking opportunities for Clinical,Marketing, R&D, ... biotech and medical technology companies. Listed below ...
... Genmab,s Partner Roche has Filed an IND With the US FDA for ... ... A/S (OMX: GEN),announced today that its partner Roche has filed an Investigational ... antibody developed under the companies, collaboration. Genmab will,receive a milestone payment from ...
... Reliant Pharmaceuticals,Inc. today announced that it has filed ... Exchange Commission for an initial public offering,of its common ... issued common stock and that certain stockholders may sell,a ... Goldman, Sachs & Co. and Merrill Lynch & ...
Cached Biology Technology:Pfizer, Genentech, Amgen, Bayer, Wyeth, Abbott, Merck and Additional Leading Pharmaceutical Companies Participating During ExL Pharma's Fall Line Up! 2Roche Files IND for Second Genmab Antibody 2Reliant Pharmaceuticals Announces the Filing of Registration Statement on Form S-1 For an Initial Public Offering 2
(Date:11/10/2014)... began appearing on U.S. store shelves in early 2010, ... since. The small packets can be tossed into a ... liquid or powder. The convenience, though, has come with ... researchers at Nationwide Children,s Hospital found that from 2012 ... 17,230 children younger than 6 years of age swallowing, ...
(Date:11/7/2014)... Florida , November 6, 2014 ... authentication for better mobile security revolutionizing online transactions.  Companies in ... Alibaba Holdings Ltd. (NYSE: BABA ), Google Inc. ... MSFT ), eBay Inc. (NASDAQ: EBAY ) and ... NXTD and NXTDW), a biometric authentication company focused ...
(Date:11/6/2014)... an asset for a predator. Except when that predator runs ... beetle, relative to its size, is the fastest creature on ... lengths per second (at about five miles per hour). The ... the sprinting gold from the tiger beetle, a person would ... tiger beetle has a problem. At peak speeds, everything becomes ...
Breaking Biology News(10 mins):Study finds laundry detergent pods, serious poisoning risk for children 2Universal Authentication Methods Provide More Secure Operations for Biometrics Devices - Company Joins FIDO Alliance for Consumer Protection 2Universal Authentication Methods Provide More Secure Operations for Biometrics Devices - Company Joins FIDO Alliance for Consumer Protection 3Universal Authentication Methods Provide More Secure Operations for Biometrics Devices - Company Joins FIDO Alliance for Consumer Protection 4Universal Authentication Methods Provide More Secure Operations for Biometrics Devices - Company Joins FIDO Alliance for Consumer Protection 5Universal Authentication Methods Provide More Secure Operations for Biometrics Devices - Company Joins FIDO Alliance for Consumer Protection 6The tiger beetle: Too fast to see 2
... of microbes colonizing and thriving on flecks of plastic ... of microbial communities that they have dubbed the "plastisphere." ... Environmental Science & Technology , the scientists say the ... and raises a host of questions: How will it ...
... of antibacterial soaps containing the chemical triclocarban may harm ... University of Tennessee, Knoxville. The study, which was ... may reduce the survival rates of babies. Rebekah ... degree in public health and nutrition, and Jiangang Chen, ...
... available in French . ... and Alberta Innovates Bio Solutions have partnered to support a $1.4 ... foodborne illness caused by Listeria bacteria. , The project, ... sequence and map the genomes of many Listeria strains ...
Cached Biology News:Scientists discover thriving colonies of microbes in ocean 'plastisphere' 2UT study: Chemical in antibacterial soaps may harm nursing babies 2New genomics research project to eliminate Listeria from food supply 2
Prepared by multi-temperature ethanol fractionation with extensive charcoal treatment and dialysis.• Assay: ≥ 95 % (HPCE)• pH ~5.2 (10 mg/mL in 0.15 M NaCl)...
Collected from animals that are 16 to 18 months old. Sterile, Cell culture tested, ID clarifier: USA Origin...
Contact us for more information...
Contact us for more information...
Biology Products: